Air Liquide’s Healthcare business is pursuing its development in the US with the acquisition of Pacific Science, Inc, a provider of cryobiology equipment and services to biobanks,

Based in Torrance, California, Pacific Science is involved in the field of cryobiology – an increasingly interesting application for the Air Liquide Group.

The transaction, effective as of 1st May, was made by Air Liquide Healthcare America Corporation, Air Liquide’s American Healthcare subsidiary, and strengthens the company’s ever-growing healthcare network in the US and beyond.

Cryobiology is a promising area for Air Liquide. Across the world, Air Liquide helps ensure the quality and the operability of stored biological samples. North America alone represents more than 40% of this fast growing market, with its most dynamic markets located on the East and West coasts.

Jean-Marc de Royere, Senior Vice-President in charge of Healthcare and a member of Air Liquide’s Executive Committee, reflected on the expertise acquired, “We are pleased to welcome Pacific Science into our Healthcare organisation. We value the expertise they have developed as a dedicated services outfit.”

“With this latest acquisition in the United States, we can bring biobanks the comprehensive offering that many expect.”

Pacific Science, Inc., will complement Air Liquide’s offering to American hospitals, particularly on the West Coast. It is also a channel through which the company’s cryobiology solutions can be brought to the US market, including designs for biobanks, vacuum line installations, liquid nitrogen supply, freezing and storage capacity, global process monitoring and cell tracking.